Improving Biopsies using Magnetic Nanoparticles
使用磁性纳米颗粒改善活检
基本信息
- 批准号:8337490
- 负责人:
- 金额:$ 0.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-20 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Lymphocytic LeukemiaAntibodiesAntineoplastic AgentsApplications GrantsAreaBindingBiochemicalBiocompatibleBiologicalBiopsyBlood VesselsBlood specimenBone MarrowBone marrow biopsyBreastBreast DiseasesCancerousCellsCharacteristicsChildClinicalClinical TrialsCollecting CellCollectionCytometryDetectionDevelopmentDiseaseDrug usageDysmyelopoietic SyndromesExcisionGoalsHealthHeatingHodgkin DiseaseHumanHuman bodyInstitutional Review BoardsLabelLeadLeftLifeMagnetismMalignant NeoplasmsMarrowMeasurementMeasuresMetalsMethodologyMethodsMicroscopicMonitorNanostructuresNanotechnologyNatureNeedle biopsy procedureNeedlesOvarianOvarian DiseasesPainPatientsPhasePlasticsProceduresProcessPropertyProstateProstatic DiseasesRadialRandomizedReportingResidual NeoplasmSamplingSensitivity and SpecificitySiteSpecificityStagingT-Cell LeukemiaTechniquesTestingTherapeuticTherapeutic AgentsTherapeutic InterventionTimeTissuesangiogenesisbasebonecancer cellcancer sitecancer typecell typechemotherapyclinical applicationcontrolled releasedesignexperiencehyperthermia treatmentimprovedleukemiamagnetic fieldmillisecondmovienanoparticlenanosystemsnovelolder patientoutcome forecastparticleprogramssensortool
项目摘要
DESCRIPTION (provided by applicant): In children with acute lymphomatic leukemia (ALL) and in myelodysplastic syndrome (MDS) with older patients it is extremely important to measure the minimal residual disease (MRD) to monitor the progress of chemotherapy at early stages Such measurements determine the prognosis, efficacy, and levels of the treatment. The normal method for detection and monitoring is through bone marrow biopsies. Unfortunately, this method requires multiple biopsies to obtain sufficient samples and these must be made at periodic intervals to monitor the treatment. It is possible to substantially improve the efficiency of biopsies through the use of appropriately labeled magnetic nanoparticles and using magnetic collection methods. These antibody-labeled magnetic nanoparticles seek out, and attach themselves to, cancer cells, which can then be collected magnetically. This grant application describes the methodology behind this biopsy technique using a }smart} magnetic biopsy needle making it possible to substantially increase the efficiency of the biopsy as well as the specificity for particular leukemia cancer types but also including the sampling of metastatic rare cancer cells in the marrow. By using magnetic nanoparticles coated with anti-cancer agents and magnetically concentrated, direct therapeutic intervention at the cancer site is possible. PUBLIC HEALTH RELEVANCE: Nanotechnology for Disease Detection, Magnetic Nanoparticles for targeting Disease, Magnetic Needle for Bone Marrow Biopsy
描述(由申请人提供):在患有急性淋巴白血病(全部)的儿童中以及与老年患者的骨髓塑性综合征(MDS)中,测量最小的残留疾病(MRD)非常重要,以监测早期阶段化学疗法的进展,例如早期的测量结果决定了治疗的预后,疗效和治疗水平。检测和监测的正常方法是通过骨髓活检。不幸的是,此方法需要多个活检才能获得足够的样本,必须定期进行这些样本以监测治疗。通过使用适当标记的磁性纳米颗粒并使用磁收集方法,可以实质上提高活检的效率。这些抗体标记的磁性纳米颗粒会寻找并将其固定在癌细胞上,然后可以磁性地收集。该赠款应用使用A} smart}磁性活检针头描述了这种活检技术背后的方法,从而可以实质上提高活检的效率以及特定白血病癌症类型的特异性,但还包括对骨髓中转移性稀有癌细胞的取样。通过使用覆盖有抗癌药物的磁性纳米颗粒并磁浓缩,可以在癌症部位进行直接治疗干预。公共卫生相关性:用于疾病检测的纳米技术,用于靶向疾病的磁性纳米颗粒,用于骨髓活检的磁针
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD R FLYNN其他文献
EDWARD R FLYNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD R FLYNN', 18)}}的其他基金
Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer
快速通道:卵巢癌生物磁体内成像
- 批准号:
7780637 - 财政年份:2008
- 资助金额:
$ 0.62万 - 项目类别:
Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer
快速通道:卵巢癌生物磁体内成像
- 批准号:
7386095 - 财政年份:2008
- 资助金额:
$ 0.62万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of Monoclonal Antibodies To Treat Pancreatic Cancer
开发治疗胰腺癌的单克隆抗体
- 批准号:
8589430 - 财政年份:2013
- 资助金额:
$ 0.62万 - 项目类别:
Homogeneous assay for monoclonal antibody detection in serum
血清中单克隆抗体检测的均相测定
- 批准号:
8007141 - 财政年份:2011
- 资助金额:
$ 0.62万 - 项目类别:
Enhancement of Antileukemic Activity by Gold Nanoparticles
金纳米粒子增强抗白血病活性
- 批准号:
7661247 - 财政年份:2009
- 资助金额:
$ 0.62万 - 项目类别:
Enhancement of Antileukemic Activity by Gold Nanoparticles
金纳米粒子增强抗白血病活性
- 批准号:
7867890 - 财政年份:2009
- 资助金额:
$ 0.62万 - 项目类别: